
While it may not always seem like it, our world is slowly becoming more eco-conscious. People, and particularly those in younger generations, are recognizing the threats of climate change and looking for ways to contribute to a healing effort. There’s still a great deal of work to be done though, and right now, in the spring of 2020, we may be at something of a crossroads.








Syngenta and Novozymes are entering the commercialization phase of the biofungicide Taegro. The two companies originally joined forces in 2012 to develop and market the product, and have now received the first wave of product approvals in Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Honduras, Italy, Netherlands, Romania, Slovenia, Spain, and United Kingdom. Several other approvals are expected across the EU and Latin America during the next 12 months, which will enable multiple product launches in 2020.